In this respect, the pharmacological inhibition of GPR17 by montelukast (a drug already known for its anti‐asthmatic effect) was shown to reduce the extent of damage and restore brain connectivity and remyelination in ischaemic stroke mice [19]. This evidence concerns the gene GPR17 and ischemic stroke.